Trading Pair Launch: Bitget officially launched the THQ/USDT trading pair on December 11, 2025, allowing immediate deposits, which is expected to attract more users and enhance Bitget's market share.
Reward Campaign Initiation: To celebrate the listing of THQ, Bitget Launchpool has introduced a total reward of 3,016,600 THQ, encouraging users to lock BGB or THQ, which is anticipated to increase user engagement and platform activity.
CandyBomb Campaign: Bitget also launched a CandyBomb campaign offering 683,300 THQ in rewards, aimed at attracting new users, which is expected to boost registration rates and trading volumes, further solidifying its market position.
AI Protocol Innovation: Theoriq, as a decentralized AI protocol, combines on-chain smart contracts with off-chain AI computation to drive autonomous multi-agent systems in Web3, which is expected to create new growth opportunities in the decentralized finance sector.
THQ
$18.66+Infinity%1D
Analyst Views on THQ
Wall Street analysts forecast THQ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THQ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast THQ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THQ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 18.640
Low
Averages
High
Current: 18.640
Low
Averages
High
No data
About THQ
abrdn Healthcare Opportunities Fund (the Fund), formerly Tekla Healthcare Opportunities Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. The Fund invests up to 20 % of managed assets, measured at the time of investment, in the debt of healthcare companies. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. It invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
